By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Encinitas  California    U.S.A.
Phone: n/a Fax: n/a


Start Up

Company News
Excaliard Release: RiverVest Venture Partners Sells Four Successful Life Science Companies for More than $1 Billion 2/7/2012 8:39:13 AM
Pfizer Inc. (PFE) Completes Acquisition of Excaliard 12/2/2011 9:13:34 AM
Isis Pharmaceuticals, Inc. (ISIS) to Receive Up to $14 Million from Pfizer Inc. (PFE) for Its Acquisition of Excaliard 11/22/2011 6:49:36 AM
Excaliard Announces Positive Results From Three Phase 2 Clinical Trials for EXC 001, Showing Significant Improvement in Both Hypertrophic and Fine Line Scarring 1/10/2011 7:25:36 AM
Excaliard Appoints Thomas Wiggans to Chairman of the Board 10/18/2010 7:18:32 AM
Excaliard Announces Positive Data From Phase 2 Clinical Trial of Its Anti-Scarring Drug, EXC 001 8/4/2010 8:42:34 AM
Excaliard Initiates Phase 2 Trials in U.S. for its Skin Scarring Drug, EXC 001 1/5/2010 11:32:18 AM
Excaliard, an Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials 10/29/2009 7:29:52 AM
Excaliard Contracts BioTox Sciences for Preclinical Research Services 11/6/2008 3:06:26 PM
Excaliard Appoints Lincoln Krochmal, MD, President & Chief Executive Officer and Jeffrey Jenson, Head of Clinical Operations 10/10/2008 8:16:40 AM